title: Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque.
abstract: A cardinal feature of Parkinson's disease (PD) is muscle hypertonicity, i.e. rigidity. Little is known about the axial tone in PD or the relation of hypertonia to functional impairment. We quantified axial rigidity to assess its relation to motor symptoms as measured by UPDRS and determine whether rigidity is affected by levodopa treatment. Axial rigidity was measured in 12 PD and 14 age-matched controls by directly measuring torsional resistance of the longitudinal axis to twisting (+/-10 degrees ). Feet were rotated relative to fixed hips (Hip Tone) or feet and hips were rotated relative to fixed shoulders (Trunk Tone). To assess tonic activity only, low constant velocity rotation (1 degrees /s) and low acceleration (<12 degrees /s(2)) were used to avoid eliciting phasic sensorimotor responses. Subjects stood during testing without changing body orientation relative to gravity. Body parts fixed against rotation could translate laterally within the boundaries of normal postural sway, but could not rotate. PD OFF-medication had higher axial rigidity (p<0.05) in hips (5.07 N m) and trunk (5.30 N m) than controls (3.51 N m and 4.46 N m, respectively), which did not change with levodopa (p>0.10). Hip-to-trunk torque ratio was greater in PD than controls (p<0.05) and unchanged by levodopa (p=0.28). UPDRS scores were significantly correlated with hip rigidity for PD OFF-medication (r values=0.73, p<0.05). Torsional resistance to clockwise versus counter-clockwise axial rotation was more asymmetrical in PD than controls (p<0.05), however, there was no correspondence between direction of axial asymmetry and side of disease onset. In conclusion, these findings concerning hypertonicity may underlie functional impairments of posture and locomotion in PD. The absence of a levodopa effect on axial tone suggests that axial and appendicular tones are controlled by separate neural circuits.
authors: Neurological Sciences Institute, Department of Neurology, Oregon Health & Science University, 505 NW 185th Ave, Beaverton, OR 97006, USA. wrightw@ohsu.edu
authors: W G
authors: WG
authors: Wright
authors: V S
authors: VS
authors: Gurfinkel
authors: J
authors: J
authors: Nutt
authors: F B
authors: FB
authors: Horak
authors: P J
authors: PJ
authors: Cordo
mesh_terms: D000005:Abdomen; D000054:Acceleration; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D005260:Female; D006615:Hip; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000209:etiology* / Q000503:physiopathology*; D009127:Muscle Rigidity / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D011187:Posture; D012399:Rotation; D012720:Severity of Illness Index; D013909:Thorax; D019415:Torque
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa
references: Mov Disord. 2006 Aug;21(8):1088-97
references: 16671073
references: J Neurol Neurosurg Psychiatry. 2000 May;68(5):595-600
references: 10766889
references: Chin Med J (Engl). 1999 Sep;112(9):812-5
references: 11717952
references: Eur Neurol. 1989;29 Suppl 1:13-8
references: 2653833
references: J Spinal Disord. 1995 Aug;8(4):253-63
references: 8547765
references: J Neurol Sci. 2006 Oct 25;248(1-2):196-204
references: 16806270
references: Rinsho Shinkeigaku. 1996 Oct;36(10):1129-35
references: 8997136
references: J Neurophysiol. 1996 Jun;75(6):2380-96
references: 8793751
references: J Neurol. 2006 Nov;253(11):1404-13
references: 16788773
references: Electroencephalogr Clin Neurophysiol. 1993 Aug;89(4):261-8
references: 7688690
references: J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):190-6
references: 9489529
references: Neurology. 1988 Apr;38(4):540-5
references: 3352908
references: J Neurol. 2007 Feb;254(2):202-9
references: 17334954
references: Acta Neurol Scand. 1992 Sep;86(3):226-9
references: 1414237
references: Prog Brain Res. 2004;143:231-7
references: 14653168
references: J Neurophysiol. 2006 Nov;96(5):2678-87
references: 16837660
references: Ergonomics. 2004 Mar 15;47(4):370-415
references: 14680997
references: J Physiol. 1915 May 12;49(4):147-56
references: 16993283
references: J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1245-54
references: 15314109
references: J Neurol Sci. 1996 Feb;135(2):168-72
references: 8867074
references: J Biomech. 1997 Jul;30(7):679-88
references: 9239547
references: Mov Disord. 1997 Jan;12(1):24-32
references: 8990050
references: Prog Brain Res. 1964;11:178-202
references: 14300477
references: Rinsho Shinkeigaku. 1993 Jan;33(1):27-35
references: 8334771
references: J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):72-6
references: 2709038
references: J Gerontol A Biol Sci Med Sci. 2000 Aug;55(8):M441-5
references: 10952366
references: Exp Brain Res. 2004 Jun;156(4):524-8
references: 15127173
references: J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):815-21
references: 16574736
references: Mov Disord. 2003 May;18(5):496-502
references: 12722162
references: Neurology. 1982 Mar;32(3):246-51
references: 7199634
references: Brain. 1992 Aug;115 ( Pt 4):1167-80
references: 1393509
references: Can J Neurol Sci. 1995 Nov;22(4):280-5
references: 8599770
references: Brain. 2003 Dec;126(Pt 12):2648-55
references: 12937076
references: J Neurol Sci. 1985 May-Jun;69(1-2):37-46
references: 4009205
references: J Neurosurg. 2005 Aug;103(2):252-5
references: 16175854
references: J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):267-74
references: 12185157
references: Brain Res. 1994 Nov 21;664(1-2):178-88
references: 7895027
references: Clin Neurophysiol. 2007 Jul;118(7):1602-6
references: 17452124
references: Clin Neurophysiol. 2006 Oct;117(10):2302-7
references: 16920016
references: J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):645-8
references: 8971118
references: J Spinal Disord. 1992 Dec;5(4):390-6; discussion 397
references: 1490035